Mahmoud Elsawy, MD, M.Sc., DRCPSC.

Biography

Dr. Elsawy is an Associate Professor of Medicine, a Hematologist/Transplant and Cellular Therapy Specialist, and The Medical Director of NSH IEC (CAR T-Cell) Therapy Program. He is the local principal investigator on several leukemia and cell therapy clinical trials in NS. Dr. Elsawy led an interdisciplinary team to establish the first CAR T-cell therapy Program in Atlantic Canada.

Research interests

Dr. Elsawy’s research interests are focused on the management of myeloid malignancies in older adults and on providing Immune Effector Cell Therapy (IEC) e.g., CAR T-cell therapy. Additionally, he has a special interest in making individualized treatment decisions guided by incorporating patients’ comorbidity assessment and studying patient reported outcomes (PROs) and quality of life. Dr. Elsawy is actively engaged in building local capacity in NS for point-of-care manufacturing of academic CAR T-cell products as part of a national effort.

Education and certification

Fellowship:

• Post-doctoral fellowship: scholarship award at Fred Hutch to study transplant and cellular therapy under mentorship of Dr. Mohamed Sorror, University of Washington, Seattle, USA
• Leukemia and Bone Marrow Transplant Fellowship: BC Cancer Agency, Vancouver, Canada

Residency:

• Internal Medicine and hematology-oncology residency: National Cancer Institute, Cairo University, Egypt

Medical school:

• Cairo University School of Medicine, Egypt. Graduated with honors.

Degrees:

• MSc, hematology-oncology: National Cancer Institute, Cairo University, Egypt
• Diplomate of the American Board of Internal Medicine: Internal Medicine
• Diplomate of the American Board of Internal Medicine: Hematology
• Diplomate of the Royal College of Physicians and Surgeons of Canada: Hematopoietic Stem Cell Transplant and Cellular Therapy

Membership

• Cell Therapy Transplant Canada: Board of Directors (Treasurer)
• Royal College of Physicians and Surgeons of Canada Area of Focused Competence Committee in HSCT and Cellular Therapy: voting member
• Canadian Leukemia Study Group: Academic Advisory Group member
• American Society of Hematology: member
• American Society of Transplantation and Cell Therapy: member

Awards

Dr. Elsawy was honored to be the recipient of 2023 Doctor Nova Scotia Dr. William Grigor Award for his role in advancing research and treatment for Nova Scotians with blood cancer through the introduction of CAR T- cell therapy in NS by establishing the first in Atlantic Canada CAR T-cell Therapy Program in Halifax.

Publications

Google Scholar profile